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disorders in the Democratic Republic of Congo, a recent study has shown
that pregnant women in Lubumbashi were still iodine deficient. Our objective
was to assess thyroid function in this population. Methods: In a cross-
sectional study conducted in maternity units from three different socioeconomic
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thyroperoxidase antibodies were measured in 225 pregnant women attending
antenatal visits, in 75 women who recently delivered, and in 75 nonpregnant
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and 1.16 ng/dL for free thyroxine (p&lt;0.001); and 13.3, 9.5, and 10.4 ng/mL
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Women in Lubumbashi, Democratic Republic of Congo
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Background: Despite notable progress in the fight against iodine deficiency disorders in the Democratic Republic
of Congo, a recent study has shown that pregnant women in Lubumbashi were still iodine deficient. Our
objective was to assess thyroid function in this population.
Methods: In a cross-sectional study conducted in maternity units from three different socioeconomic areas in
Lubumbashi, serum thyrotropin, free thyroxine, thyroglobulin, and thyroperoxidase antibodies were measured
in 225 pregnant women attending antenatal visits, in 75 women who recently delivered, and in 75 nonpregnant
controls. The outcome was the prevalence of thyroid dysfunction.
Results: Median values in pregnant women, women who recently delivered, and nonpregnant women were
1.80, 2.80, and 1.54mIU/L for thyrotropin ( p < 0.001); 0.85, 1.11, and 1.16 ng/dL for free thyroxine ( p < 0.001);
and 13.3, 9.5, and 10.4 ng/mL for thyroglobulin ( p = 0.01), respectively. The prevalence of thyroid dysfunction in
pregnant women, in women who recently delivered, and in nonpregnant women was 31%, 8%, and 20% for
isolated hypothyroxinemia ( p < 0.001); 12%, 24%, and 5% for subclinical hypothyroidism ( p = 0.002); 8%, 3%, and
3%, for overt hypothyroidism ( p = 0.09); and 5%, 13%, and 4%, for positive thyroperoxidase antibodies ( p = 0.03),
respectively. In multiple logistic regression, women who were pregnant or who recently delivered, who lived in
a poor socioeconomic area, and who had low urinary iodine concentration were more likely to have an increased
serum thyrotropin: odds ratio (OR) = 3.43 (95% confidence interval [CI] 1.23–9.53) for pregnancy, OR = 4.49 [CI
1.66–15.01] for postpartum period, OR = 3.68 [CI 1.85–7.35] for semiurban area, and OR = 0.44 [CI 0.19–0.96] for
urinary iodine concentration ‡ 250 lg/L.
Conclusions: Our results show that there is a high prevalence of thyroid dysfunction in pregnant women of
Lubumbashi, and this high prevalence is associated with iodine deficiency. To prevent obstetrical adverse
outcomes and neurological damage in children, iodine supplementation is needed before conception or in early
pregnancy in Lubumbashi.
Introduction
Thyroid dysfunction is the most frequent endocrinedisorder in pregnant women. Overt hypothyroidism and
even subclinical hypothyroidism increases the risk of obstetric
complications: miscarriage, fetal death, gestational hyper-
tension, preterm birth, and low birth weight (1–5). When oc-
curring early in pregnancy, hypothyroidism can cause
cognitive and neurodevelopment retardation in children.
Moreover, thyroid autoantibodies in pregnancy are also as-
sociated with recurrent miscarriage (6) and with maternal
morbidity later in life (7). Maintaining a normal thyroid
function during pregnancy is therefore of predominant im-
portance for the mother and for the child.
Maintaining a pregnant woman in a euthyroid state is a
challenge for the thyroid gland during gestation because of an
increased thyroid hormone demand and decreased iodine
availability due to iodine transfer to the fetus and intensified
iodine urinary losses induced by the increased renal glomer-
ular filtration (8,9). Physiological adaptations take place when
iodine intake is sufficient and when there is no underlying
thyroid pathology: the increase in estrogens induces an in-
crease in thyroxine (T4)-binding globulin, which alters the
ratio between free and bound thyroid hormones; the increase
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in human chorionic gonadotropin hormone, which has thy-
rotrophic activity, induces a slight increase in free thyroxine
(FT4) with a peak at the end of the first trimester, and this
causes a transient decrease in thyrotropin (TSH) through
negative feedback on pituitary thyrotrophs (8,10–12); the
placental deiodinase III alters metabolism, distribution, and
availability of T4 for the mother and for the fetus in the second
half of gestation (12,13).
When iodine intake is mildly to moderately deficient, there
may not be enough T4 available to the fetus, and this may not
be recognized because TSH does not necessarily increase be-
cause of stable or slightly increased triiodothyronine (T3)
levels (12). Severe iodine deficiency can result in overt hy-
pothyroxinemia, goiter, and the spectrum of iodine deficiency
disorders (11).
The Democratic Republic of Congo has adopted a salt io-
dization strategy in 1993 to fight against iodine deficiency
disorders, with a recommended iodine content of salt set be-
tween 30 and 100 ppm. The latest national surveys on iodine
status reported a sufficient iodine intake at the national level,
a prevalence of goiter below 1%, and availability of iodized
table salt in more than 97% of households (14). However, a
study by Kitwa et al. (15) showed that noniodized salt was still
commercialized in Lubumbashi markets, despite the fact that
salt iodization is mandatory, and the iodine content of table
salt collected in households was under the threshold limit of
15 ppm for 36.3% of samples. In a recent study, we showed
that iodine intake varied across socioeconomic levels in Lu-
bumbashi, and that pregnant women in rural and semiurban
areas of Lubumbashi were moderately and mildly iodine
deficient, with a median urinary iodine of 97 and 145 lg/L,
respectively, while pregnant women in an urban area had an
adequate iodine intake, with a median urinary iodine of
168 lg/L (16). As thyroid dysfunctionmight be a consequence
of iodine deficiency, the objective of the present study was to
assess the prevalence of thyroid dysfunction and its potential
link with iodine deficiency in these pregnant women in
Lubumbashi.
Subjects and Methods
We conducted a cross-sectional study between March 2009
and February 2011 in threematernity units from Lubumbashi.
As we did not know the size of the population in the different
districts of Lubumbashi, and for the purpose of sample rep-
resentativeness, we recruited women in three maternities
serving populations from different socioeconomic strata. Lu-
bumbashi University Clinics, located in an urban area, serves
a population with the highest socioeconomic status; Bon-
gonga Health Centre, located in a semiurban area, provides
services to individuals with a middle status; and Katuba
General Hospital, located in a rural area, serves a population
with the lowest socioeconomic status. The study was de-
signed to assess thyroid function of pregnant women and its
relationship with their iodine intake.
The sample size was calculated to have a power of 80% to
detect a difference of at least 50lg/L in urinary iodine con-
centration (UIC) between pregnant women and nonpregnant
controls, using a significance level of 5% and assuming a
balance between the three trimesters of pregnancy and the
three maternities. A total of 375 women were recruited, and
225 pregnant women were randomly selected among those
attending antenatal visits: 25 in the 1st trimester of pregnancy,
25 in the 2nd, and 25 in the 3rd trimester, in each of the three
maternity units. Seventy-five nonpregnant women of child-
bearing age were selected as controls among visitors, 25 by
maternity; 75 women who recently delivered were also in-
cluded in the study at their 3rd postpartum day (25 in each
maternity unit).
Twin pregnancies were not included in the study (17), nor
were women with known thyroid disease. All participants
gave written informed consent. The study protocol was ap-
proved by the Ethics Committee of The University of Lu-
bumbashi before implementation.
Each participant gave a blood sample and a spot urine
sample for measurement of UIC. Women were questioned
about sociodemographic, clinical, and epidemiologic data.
Gestational age was calculated from the last menstrual date
and verified by ultrasonography. All blood and urine samples
were stored at - 20C until measurement in the Laboratory of
Lubumbashi University Clinics.
Iodine was measured in spot urine samples using a modi-
fied Sandell–Kolthoff reaction between arsenic and cerium,
after mineralization with ammonium persulfate digestion, by
microplate reading (Multiskan EX Microplate Photometer,
Primary EIA V.2.1–0, Labsystems; Thermo Scientific). UIC
was used to categorize iodine intake as proposed by the
World Health Organization (18): iodine intake was consid-
ered adequate during pregnancy when the median UIC was
found to be between 150 and 249 lg/L, deficient when the
median UIC was < 150 lg/L, more than adequate when the
median UIC was between 250 and 499 lg/L, and excessive
when the median UIC was ‡ 500lg/L. In nonpregnant
women, iodine intake was considered adequate if the median
UIC was between 100 and 199lg/L. Results of the iodine
status of women in Lubumbashi have been published previ-
ously and are summarized in Table 1 (16).
We assessed thyroid function by measuring serum TSH
and FT4. Blood samples were also analyzed for free triiodo-
thyronine (FT3), thyroglobulin (Tg), and antithyroperoxidase
antibody (TPOAb) concentrations. Measurements were made
by an immunoenzymatic colorimetric method with the ETI-
System fast reader ELX 800, and using commercial kits sup-
plied by DiaSorin (DiaMetra; SA/NV DiaSorin Benelux). For
TSH, we used the reference ranges established in 2011 by
the American Thyroid Association Guidelines for pregnant
women (19) and we used the Manufacturer’s reference ranges
for other biochemical analyses. The reference ranges for TSH
were 0.1–2.5mIU/L in the 1st trimester, 0.2–3.0mIU/L in the
2nd trimester, 0.3–3.0mIU/L in the 3rd trimester, 0.3–
3.6mIU/L for the postpartum period, and 0.3–4.0mIU/L for
nonpregnant women; for FT4, it was 0.8–2.0 ng/dL for non-
pregnant women and 0.8–2.2 ng/dL for pregnant women; for
FT3, it was 1.4–4.2 pg/mL for nonpregnant women and 1.8–
4.2 pg/mL for pregnant women; for Tg, it was lower than
40 ng/mL in all cases; TPOAbs were considered positive if
‡ 20AU/mL (AU = arbitrary units from DiaMetra kits).
Euthyroidism was defined as a normal TSH with normal
FT4. Subclinical hypothyroidism was defined as an elevated
TSH with normal FT4, overt hypothyroidism as high TSH
with low FT4, isolated hypothyroxinemia as low FT4 with
normal TSH, and subclinical hyperthyroidism was defined as
low TSH with normal FT4 (20,21). TPOAb positives were
considered apart.
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Statistical analyses
Continuous data are reported as arithmetic mean and
standard deviation when normally distributed, and as me-
dian with quartiles otherwise. Discrete data are reported as
proportions. We used the Pearson’s chi-square test to com-
pare proportions, and Mann–Whitney U or ANOVAwith the
Kruskal–Wallis test to compare medians between groups.
Correlation between continuous variables was assessed on a
log scale, using the Pearson coefficient. Logistic regression
was used to assess predictors of an increased TSH. Socio-
demographic variables (age, parity, and socioeconomic area),
group of women (pregnancy, early postpartum, or nonpreg-
nant), UIC (< 150lg/L, 150–250 lg/L, or ‡ 250 lg/L), and
TPOAb status (13,22) were initially examined by univariate
analyses; all variables with a p-value < 0.20 were submitted to
a multivariate regression analysis with a stepwise backward
elimination procedure, using p> 0.05 to remove from the
model. All tests were two sided, and the significance level was
set to 0.05. Statistical analyses were performed using SAS 9.3
statistical software.
Results
Characteristics of the participants and UICs are summa-
rized in Table 1. Pregnant women and women who recently
delivered were aged 27– 7 years. Half of the pregnant women
had 3 previous pregnancies and 25% had at least 6. Women
with at most one previous pregnancy were younger than
multiparous women (21 – 4 vs. 29– 6 years, p < 0.001). Most
women were married and nearly all were housewives. The
median UIC in pregnant women was 138lg/L (interquartile
range 57–321), lower than the median UIC in nonpregnant
controls of 204lg/L (interquartile range 95–331), p= 0.04,
with a gradient from the 1st to the 3rd trimester of gestation
(median UIC = 238 lg/L in the 1st trimester, 129lg/L in the
2nd, and 77 lg/L in the 3rd trimester, p< 0.001). About 52% of
pregnant women had a UIC below 150lg/L, 42% of pregnant
women had a UIC below 100 lg/L, and 23% had a UIC below
50 lg/L. On a log scale, a lower UIC was associated with
greater gestational age (r = - 0.24, p < 0.001); UIC did not
correlate with age.
Tables 2, 3, and 4 report median values with quartiles for
TSH, FT4, FT3, and Tg, and proportions of TPOAb-positive
individuals, for pregnant and nonpregnant women in all
maternity units (Table 2), according to socioeconomic area
and trimesters of gestation (Table 3), as well as UIC levels
and TPOAb status (Table 4). The median TSH in pregnant
womenwas 1.80mIU/L, higher than the 1.54mIU/L found in
nonpregnant women, but lower than the 2.80mIU/L ob-
served in postpartum women ( p< 0.001). During pregnancy,
TSH increased with trimester in rural ( p = 0.19) and semi-
urban areas ( p< 0.001). TSH decreased with parity, but the
Table 1. Age, Parity, and Urinary Iodine Concentration of 375 Childbearing-Aged Women
in Lubumbashi, Democratic Republic of Congo
Age, years, Parity, UIC, lg/L,
All maternity units mean –SD (min–max) p50 (p25–p75) p50 (p25–p75)
All pregnant (n = 225) 27– 7 (15–43) 3 (2–6) 138 (57–321)
1st trimester (n= 76) 28– 6 (15–42) 3 (2–6) 238 (115–387)
2nd trimester (n = 71) 26– 7 (15–43) 3 (2–5) 129 (69–286)
3rd trimester (n = 78) 27– 7 (16–41) 3 (1–6) 77 (27–222)
p-valuea 0.005 0.24 < 0.001
Postpartum (n= 75) 27– 7 (15–43) 3 (2–6) 144 (97–300)
Nonpregnant (n= 75) 32– 8 (17–52) 2 (0–7) 204 (95–331)
p-valueb < 0.001 < 0.001 0.09
Adapted from Habimana et al. (16).
aComparison between trimesters of gestation.
bComparison between pregnant, postpartum, and nonpregnant women.
UIC, urinary iodine concentration.
Table 2. Biochemical Thyroid Indices in 375 Childbearing-Aged Women
in Lubumbashi, Democratic Republic of Congo
All maternity units TSH, mIU/L FT4, ng/dL FT3, pg/mL Tg, ng/mL TPOAb positive
All pregnant (n = 225) 1.80 (1.13–2.63) 0.85 (0.67–1.00) 1.44 (1.01–2.23) 13.3 (4.7–23.2) 12 (5.3)
1st trimester (n= 76) 1.54 (0.82–2.12) 0.80 (0.55–0.99) 1.56 (0.81–2.75) 9.2 (3.0–16.4) 7 (9.2)
2nd trimester (n = 71) 1.99 (1.28–2.78) 0.86 (0.71–0.98) 1.41 (1.09–2.00) 14.3 (5.3–23.7) 5 (7.0)
3rd trimester (n = 78) 2.06 (1.34–2.83) 0.86 (0.68–1.04) 1.52 (1.07–1.98) 15.9 (7.4–25.5) 0 (0.0)
p-valuea 0.005 0.24 0.78 0.01 0.02
Postpartum (n= 75) 2.80 (1.75–3.78) 1.11 (0.94–1.45) 0.91 (0.60–1.60) 11.8 (8.0–15.1) 10 (13.3)
Nonpregnant (n= 75) 1.54 (1.11–2.98) 1.16 (0.79–1.38) 1.71 (1.28–2.37) 11.8 (8.5–15.6) 3 (4.0)
p-valueb < 0.001 < 0.001 < 0.001 0.01 0.03
Data are medians with quartiles in parentheses, and number and percentages in parentheses for TPOAb positive.
aComparison between trimesters of gestation.
bComparison between pregnant, postpartum, and nonpregnant women.
FT3, free triiodothyronine; FT4, free thyroxine; Tg, thyroglobulin; TPOAb, antithyroperoxidase antibody; TSH, thyrotropin.
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association was borderline (r = - 0.13, p= 0.05), and maternal
age did not modify this association. Pregnant women with a
UIC < 150lg/L had higher TSH levels than women with a
UIC ‡ 250 lg/L ( p = 0.002).
Themedian FT4 of pregnant womenwas 0.85 ng/dL, lower
than the one found in nonpregnant and in postpartumwomen
(1.16 and 1.11 ng/dL, respectively, p < 0.001). The median
FT3 was 1.44 pg/mL in pregnant women, higher than the
0.91 pg/mL found in women who had delivered and lower
than the 1.71 pg/mL observed in nonpregnant women
( p < 0.001); FT3 and FT4 did not correlate with UIC.
Thyroid peroxidase autoantibodies were positive (TPOAb
> 20AU/mL) in 25 women: 12/225 (5%) pregnant women
(with a gradient in trimesters of gestation: 7/76 [9.2%] in the
1st trimester, 5/71 [7.0%] in the 2nd, and none [0%] in the 3rd
trimester); 10/75 (13%) women who recently delivered; and
3/75 (4%) nonpregnant women ( p= 0.03). TPOAbsweremore
often positive in pregnant women with a UIC > 250 lg/L
Table 3. Biochemical Thyroid Indices of 375 Women in Lubumbashi, Democratic Republic of Congo,
According to Socioeconomic Area
TSH, mIU/L FT4, ng/dL FT3, pg/mL Tg, ng/mL TPOAb positive
Rural area
All pregnant (n = 75) 1.99 (1.30–2.81) 0.81 (0.69–0.92) 1.46 (1.09–2.19) 15.4 (6.4–24.6) 0 (0.0)
T1 (n = 25) 1.70 (0.89–2.50) 0.99 (0.88–1.15) 1.61 (0.94–2.19) 11.3 (6.4–21.0) 0 (0.0)
T2 (n = 25) 2.07 (1.26–2.79) 0.78 (0.69–0.82) 1.57 (1.15–2.28) 14.3 (7.4–27.4) 0 (0.0)
T3 (n = 25) 2.40 (1.73–2.96) 0.73 (0.68–0.82) 1.22 (1.04–1.67) 18.7 (4.8–27.4) 0 (0.0)
p-valuea 0.19 < 0.001 0.27 0.57
Postpartum (n = 25) 2.51 (1.69–3.08) 1.45 (1.04–1.58) 1.61 (0.54–2.11) 9.8 (7.2–12.7) 0 (0.0)
Nonpregnant (n = 25) 1.71 (0.69–3.29) 0.98 (0.66–1.22) 1.64 (0.57–2.36) 11.4 (8.5–16.5) 1 (4.0)
p-valueb 0.001 < 0.001 0.78 0.002
Semiurban area
All pregnant (n = 75) 2.10 (1.15–3.38) 0.95 (0.62–1.11) 2.11 (1.42–3.22) 12.0 (5.8–18.7) 9 (12.0)
T1 (n = 26) 1.05 (0.33–1.75) 0.58 (0.33–0.79) 2.91 (1.06–3.79) 6.2 (1.5–11.9) 7 (26.9)
T2 (n = 24) 2.28 (1.41–3.34) 0.98 (0.80–1.09) 1.70 (1.33–2.29) 14.3 (6.9–25.5) 2 (8.3)
T3 (n = 25) 2.75 (2.14–4.26) 1.10 (0.98–1.27) 1.97 (1.61–2.78) 14.2 (10.5–19.5) 0 (0.0)
p-valuea < 0.001 < 0.001 0.10 0.002
Postpartum (n = 25) 3.73 (2.64–5.25) 1.09 (0.95–1.49) 0.67 (0.54–0.93) 11.9 (7.9–17.0) 1 (4.0)
Nonpregnant (n = 25) 2.26 (1.78–3.88) 1.38 (1.32–1.48) 2.25 (1.63–2.61) 9.4 (6.9–15.1) 1 (4.0)
p-valueb < 0.001 < 0.001 < 0.001 0.01
Urban area
All pregnant (n = 75) 1.43 (0.97–2.14) 0.84 (0.60–0.96) 1.10 (0.71–1.43) 12.3 (0.0–23.8) 3 (4.0)
T1 (n = 25) 1.86 (1.15–2.59) 0.76 (0.58–0.91) 1.05 (0.67–1.55) 10.1 (1.9–18.3) 0 (0.0)
T2 (n = 22) 1.43 (1.16–2.03) 0.89 (0.74–0.96) 1.09 (0.75–1.33) 14.5 (0.0–22.6) 3 (13.6)
T3 (n = 28) 1.27 (0.81–2.02) 0.80 (0.51–0.96) 1.15 (0.83–1.69) 16.4 (0.0–36.3) 0 (0.0)
p-valuea 0.17 0.34 0.68 0.35
Postpartum (n = 25) 2.08 (1.05–3.34) 1.05 (0.78–1.12) 1.06 (0.74–1.52) 11.9 (8.0–15.4) 9 (36.0)
Nonpregnant (n = 25) 1.72 (1.08–2.60) 1.02 (0.65–1.23) 1.60 (1.32–1.88) 11.9 (9.5–15.6) 1 (4.0)
p-valueb 0.14 0.009 < 0.001 0.83
Data are medians with quartiles in parentheses, and number and percentages in parentheses for TPOAb positive.
aComparison between trimesters of gestation.
bComparison between pregnant, postpartum, and nonpregnant women.
T1, 1st trimester; T2, 2nd trimester; T3, 3rd trimester.
Table 4. Biochemical Thyroid Indices in 220 Pregnant Women in Lubumbashi, Democratic Republic
of Congo, According to Urinary Iodine Concentration and Thyroperoxidase Antibody Status
TSH, mIU/L FT4, ng/dL FT3, pg/mL Tg, ng/mL TPOAb positive
UIC, lg/L
< 150 (n = 115) 2.06 (1.29–3.07) 0.86 (0.67–1.03) 1.57 (1.09–2.28) 14.2 (5.6–24.3) 1 (0.9)
150–249 (n= 35) 2.00 (1.44–2.81) 0.79 (0.67–0.97) 1.30 (1.01–2.18) 13.0 (5.6–20.9) 2 (5.7)
‡ 250 (n = 70) 1.42 (0.90–2.05) 0.85 (0.67–0.98) 1.38 (0.90–2.23) 12.3 (4.5–20.4) 8 (11.4)
p-valuea 0.002 0.58 0.44 0.45 < 0.001
TPOAb status
Positive (n= 12) 1.06 (0.45–2.85) 0.35 (0.02–0.84) 1.86 (0.70–3.09) 4.3 (0.7–9.8)
Negative (n = 213) 1.86 (1.20–2.63) 0.85 (0.69–1.00) 1.44 (1.04–2.19) 13.8 (5.4–23.4)
p-valueb 0.14 0.002 0.88 0.007
Data are medians with quartiles in parentheses, and number and percentages in parentheses for TPOAb positive.
aComparison between UIC category.
bComparison between TPOAb status.
MATERNAL THYROID DYSFUNCTION IN LUBUMBASHI 571
(11.4%, compared with 5.7% in individuals with an adequate
UIC and 0.9% with a UIC < 150 lg/L, p < 0.01). TPOAb-
positive women had lower FT4 and lower Tg levels than
TPOAb-negative pregnant women ( p< 0.01). TPOAbs were
more frequently elevated in pregnant women in the semiurban
area (12%) than in the urban environment (4%), and they were
absent in the rural area ( p= 0.03). Multiparous women were
more often TPOAb positive (8.7% vs. 1.0%, p= 0.008).
Figure 1 shows the patterns of thyroid function in partici-
pants. About 59% of pregnant women and 48% of postpartum
women had alterations in thyroid function, as compared with
33% in nonpregnant women ( p < 0.001). Isolated hypothyr-
oxinemia was more frequent in pregnant women than in other
women (31% vs. 8% in the early postpartumperiod, and 20% in
nonpregnant women, p< 0.001), but the prevalence of isolated
hypothyroxinemia was not statistically different according to
the trimester of gestation, socioeconomic area, and UIC level.
Overt hypothyroidism was also more frequent in pregnant
women: 8% versus 3% in women in the early postpartum pe-
riod and in nonpregnant women ( p= 0.09); it was less frequent
when the UIC was high: 1.4% when the UIC was ‡250lg/L
compared with 10% when the UIC < 150lg/L, and 17% when
FIG. 1. Patterns of thyroid
function in 225 pregnant
women from three maternity
units in Lubumbashi: (a) ac-
cording to trimester of preg-
nancy; (b) as compared with
75 postpartum and 75 non-
pregnant women; (c) accord-
ing to socioeconomic area
(rural, semiurban, and urban
areas); (d) according to uri-
nary iodine concentration
(UIC; low, < 150 lg/L; nor-
mal, 150–249 lg/L; high,
‡ 250lg/L). Patterns of thy-




hypo TH); subclinical hypo-
thyroidism (SubC hypo TH);
isolated hypothyroxinemia
(Hypo FT4,); and euthyroidism.
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the UIC was adequate ( p= 0.01). Subclinical hypothyroidism
was present in 12%of pregnantwomen, in 24%ofwomen in the
early postpartum period, and in 5% of nonpregnant control
women ( p= 0.002); subclinical hypothyroidism was more fre-
quent in pregnant women in semiurban and rural areas than in
the urban area ( p< 0.001) and when UIC was low: 17% when
theUIC <150lg/L, and 9% or 7%when the UICwas adequate
or excessive, respectively ( p=0.13).
Considering together overt and subclinical hypothyroid-
ism in pregnant women, proportions of hypothyroidism de-
creased as UIC increased: 26.1% of pregnant women with a
UIC < 150 lg/L, 25.7% of pregnant womenwith aUIC of 150–
249lg/L, and 8.6% of pregnant womenwith a UIC > 250lg/L
were hypothyroid (trend v2, p=0.01).
Table 5 presents factors associatedwith a high TSH inwomen
in Lubumbashi. In univariate analysis, we found a higher TSH
among women who were pregnant or who recently delivered,
in women who were living in a semiurban area, and in those
who had a normal or low UIC. TPOAb status, age, and number
of previous pregnancies were not associated with an increased
TSH. In amultivariate logistic regressionmodel performedwith
interaction terms, none of the interactions were significant, re-
flecting similar effects of one covariate across levels of another
one. Moreover, multivariate ORs were close to univariate ORs,
indicating independent effects of significant covariates. The ef-
fect of socioeconomic status on TSH can be therefore considered
as independent of the effect of UIC on TSH.
Discussion
In the present study, we found that almost 60% of pregnant
women had either isolated hypothyroxinemia or thyroid
dysfunction, compared with less than 40% of nonpregnant
women. The most frequent patterns of thyroid dysfunction
were subclinical hypothyroidism, present in 12% of pregnant
women, overt hypothyroidism in 8%, and thyroid peroxidase
antibodies positive in 5% of pregnant women.
The overall prevalence of 20% of hypothyroidism found in
this study is quite higher than what is commonly described:
0.3–0.5% for overt hypothyroidism and 2–3% for subclinical
hypothyroidism in populations (19), or 4.6–5.0% in screened
pregnant women (23). Nevertheless, our results are consis-
tent with the observations on iodine deficiency in pregnant
women fromLubumbashi: hypothyroidismwasmore frequent
in pregnant women with low UIC. When iodine intake is re-
stricted, TSH can rise up to twofold between the first trimester
and the end of gestation (13). Irrespective of our cross-sectional
design, pregnant women in the 3rd trimester had a TSH that
was 1.5-fold higher than in women in the 1st trimester. About
18.5% of pregnantwomen in the 1st trimester had a TSHhigher
than the recommend upper limit of 2.5mU/L. This finding is
very important as an increased TSH in the first trimester of
pregnancy has been associated with neurologic retardation
and lower intellectual quotient in children in the study by
Haddow et al. (24). In contrast, Lazarus et al. (23) could not
confirm a lower intellectual quotient in children of mothers
with subclinical hypothyroidism at age 3.5 years in the Con-
trolled Antenatal Thyroid Screening study. Nevertheless, an
association of maternal subclinical hypothyroidism with a
neurocognitive delay remains biologically plausible (19).
We found two to three more pregnant women with hypo-
thyroidism in rural and semiurban areas, characterized by
moderate or mild iodine deficiency, than in the iodine-
sufficient urban area. Semiurban areas of Lubumbashi are
Table 5. Factors Associated with a High Serum Thyrotropin Level Using Logistic Regression
Univariate Multivariate
n (%) Odds ratio 95% confidence interval p Odds ratio 95% confidence interval p
Socioeconomic area < 0.001 < 0.001
Rural 22 (17.6) 1.59 [0.77–3.29] 1.55 [0.74–3.26]
Semiurban 40 (32.0) 3.58 [1.82–7.03] 3.68 [1.85–7.35]
Urban 14 (11.2) 1 1
Group 0.004 0.01
Pregnancy 48 (21.3) 3.03 [1.24–7.43] 3.43 [1.23–9.53]
Postpartum 21 (28.0) 4.34 [1.64–11.52] 4.49 [1.66–15.01]
Control 7 (9.3) 1 1
UIC, lg/L 0.01 0.02
< 150 37 (24.0) 0.90 [0.49–1.68] 1.11 [0.55–2.25]
150–249 21 (25.9) 1 1
‡ 250 16 (12.0) 0.39 [0.19–0.80] 0.44 [0.19–0.96]
TPOAb status 0.97
Positive 5 (20.0) 0.98 [0.36–2.71]
Negative 71 (20.3)
Parity 0.27 0.05
0–1 24 (24.2) 1 1
2 or plus 52 (18.8) 0.73 [0.42–1.28] 0.49 [0.23–1.02]
Age, years 0.19
< 25 35 (23.8) 1
‡ 25 41 (18.1) 0.71 [0.43–1.18]
A high serum TSH: > 3mIU/L in 2nd and 3rd trimester, > 2.5mIU/L in 1st trimester, > 3.6mIU/L in early postpartum, and > 4.0mIU/L
in nonpregnant women. Bold values are statistically significant odds ratios.
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suburban agglomerations with displaced people looking for a
job and for better life conditions; these individuals are between
theunfavorable socioeconomic conditions of rural areas and the
more favorable socioeconomic conditions of urban areas. They
have more often poor infrastructures and are usually left be-
hind during health promotion campaigns. The iodine status
of pregnant women from the semiurban area showed a vast
spectrum,with the highestmedianUIC level in the 1st trimester
(306lg/L) and the lowest in the 3rd trimester (68lg/L) (16).
This might explain the higher prevalence of hypothyroidism
found in the semiurban area than in the rural area.
TSH decreased with parity in our study. This relation has
been described also by Pearce et al. (25). In a previous study
with Twite et al. (26), we showed that the thyroid volume in
this population increased with parity, and that multiparous
women hadmore often a goiter than nulliparous women. This
finding is in agreement with previous observations by
Rotondi et al. (27), who indicated that parity was one of the
thyroid-size-determining factors at least in condition of
moderate iodine deficiency. This corroborates also the notion
that thyroid alterations occurring during pregnancy continue
after pregnancy in a situation of iodine deficiency, and they
tend to persist during later pregnancies, especially when
pregnancies are very close (13). However, the previous iodine
status of these multiparous has never been assessed before
our study. Nonetheless, the problem remains unsolved for
women who begin their motherhood in conditions of iodine
deficiency and who develop hypothyroidism.
We found a quite high proportion of isolated hypothyrox-
inemia in pregnant women: 26% in the 1st trimester, 28% in
the 2nd, and 37% in the 3rd trimester. Pop et al. (28,29) have
shown that an uncorrected low concentration of FT4 at 12
weeks of gestation was associated with neurodevelopmental
retardation in children, even when the TSH was normal.
Hypothyroxinemia is frequently overestimated in pregnancy
when measuring FT4 by immunometric assays (12,30).
Nonetheless, the prevalence of hypothyroxinemia in our
study was also high in nonpregnant women (20%), where
immunoassays are not affected by alterations in binding
proteins; this argues for an actual decrease in FT4 rather than
an assay phenomenon.
We found a gradient in TPOAb positivity in pregnant
women from low (UIC < 150 lg/L) to more than adequate
iodine intake (UIC ‡ 250 lg/L); this is consistent with studies
showing an association between excessive iodine intake and
an increased risk of thyroid autoimmunity (31,32). Never-
theless, the proportion of womenwith TPOAbwas not high in
our study. This underlines the important role of iodine defi-
ciency, rather than thyroid autoimmunity, in the occurrence
of hypothyroidism in pregnant women from Lubumbashi.
Our study has some limitations. The cross-sectional design
does not allow following changes between trimesters of
pregnancy for a given woman. The nonprobability sampling
limits the external validity of pooled results. The iodine status
at an individual level cannot be assessed with a single spot
urine. A single evaluation performed in the early postpartum
period does not adequately reflect thyroid function, but
women of Lubumbashi are difficult to follow after discharge
from the maternity unit. Another limitation is the sensitivity
of FT4 immunologic assays to alterations in binding proteins
(30). Actually, the immunoenzymatic assays have less good
correlation with the gold standard, liquid chromatography in
tandem with mass spectrometry, but this sophisticated anal-
ysis is too expensive, technically complex (12), and not
available in the Lubumbashi laboratory. We partially over-
come this last limitation by using, as recommended, reference
ranges established by the manufacturer for pregnant women,
but they were not trimester-specific or ethnicity-specific or
adjusted for iodine deficiency.
Strengths of this work include the evaluation of both iodine
intake and maternal thyroid function in pregnant women
from the three trimesters of pregnancy, the comparison with
nonpregnant women of childbearing age, and the assessment
of these parameters in maternity units from different socio-
economic areas of Lubumbashi. This is the first study on
thyroid function of pregnant women in the Democratic
Republic of Congo.
Our findings suggest a high prevalence of thyroid dys-
function in pregnant women in Lubumbashi. Pregnant
women who are iodine deficient are more likely to have hy-
pothyroidism. Our results provide evidence for the need (i) to
ensure higher availability of iodized salt in households of
Lubumbashi, (ii) to include a key group of pregnant women in
national surveys of iodine status, and (iii) to seriously con-
sider implementing iodine supplementation during antenatal
visits in early pregnancy or even before conception.
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